Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03021746 · ClinicalTrials.gov registry record · NA

Fostering Sustainability Through Diabetes Self-Management Support

A NA study, sponsored by University of Michigan.

Completed
Registry status
NA
Development phase
358
Enrollment target

NCT03021746: Completed NA study, sponsored by University of Michigan.

NCT03021746 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 358 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03021746, a NA study, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
NA
Development phase
358 participants
Enrollment target

Study Summary

To understand the effectiveness of three approaches to address diabetes self-management support compared to enhanced usual care in church-based settings.

Primary Outcome

An A1C test is a blood test that reflects one's average blood glucose levels over the previous 3 months.

Interventions

  • BEHAVIORAL Diabetes Self Management Support (DSMS)

Trial Details

FieldValue
Enrollment Target 358 participants
Start Date 2016-03
Est. Completion 2021-08-31
Phase NA
University of Michigan

1,327 total trials

What the finished NCT03021746 record still lists

NCT03021746 is an interventional study that assigns participants to a tested intervention. The registered 358 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower).

The record links to 0 conditions, and to 1 intervention - of which Diabetes Self Management Support (DSMS) is the first listed.

NCT03021746 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03021746 about?

NCT03021746 is a clinical study titled "Fostering Sustainability Through Diabetes Self-Management Support". To understand the effectiveness of three approaches to address diabetes self-management support compared to enhanced usual care in church-based settings.

What is the current status of trial NCT03021746?

This trial is currently completed. It is a NA study. The enrollment target is 358 participants. The study started on 2016-03. Estimated completion is 2021-08-31.

What interventions are being tested in trial NCT03021746?

The interventions under investigation include: Diabetes Self Management Support (DSMS) (BEHAVIORAL).

Who is sponsoring clinical trial NCT03021746?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03021746's enrollment target sits among peer trials

358 288th of 2000 higher than 1,712 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04373317 · 358 participants · Phase 4

    Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis

  • NCT05684965 · 358 participants · Phase 1

    XTX301 in Patients With Advanced Solid Tumors

  • NCT05824975 · 358 participants · Phase 1

    A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)

  • NCT06480227 · 358 participants · NA

    Trial of Transurethral Bulking Agent Injection Versus Single-Incision Sling for Stress Urinary Incontinence

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT03021746, the US trial registry maintained by the National Library of Medicine. NCT03021746 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.